|
MedChemExpress
si rna targeting nrf2 Si Rna Targeting Nrf2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/si rna targeting nrf2/product/MedChemExpress Average 96 stars, based on 1 article reviews
si rna targeting nrf2 - by Bioz Stars,
2026-02
96/100 stars
|
Buy from Supplier |
|
Thermo Fisher
cho cells transfected construct sirna allstar negative control qiagen si03650318 control sirna Cho Cells Transfected Construct Sirna Allstar Negative Control Qiagen Si03650318 Control Sirna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cho cells transfected construct sirna allstar negative control qiagen si03650318 control sirna/product/Thermo Fisher Average 86 stars, based on 1 article reviews
cho cells transfected construct sirna allstar negative control qiagen si03650318 control sirna - by Bioz Stars,
2026-02
86/100 stars
|
Buy from Supplier |
|
Qiagen
anti his antibody alexa488 conjugate Anti His Antibody Alexa488 Conjugate, supplied by Qiagen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti his antibody alexa488 conjugate/product/Qiagen Average 94 stars, based on 1 article reviews
anti his antibody alexa488 conjugate - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Qiagen
predesigned allstar negative control sirna Predesigned Allstar Negative Control Sirna, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/predesigned allstar negative control sirna/product/Qiagen Average 90 stars, based on 1 article reviews
predesigned allstar negative control sirna - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
BONAC Corporation
rnai negative control sirna Rnai Negative Control Sirna, supplied by BONAC Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rnai negative control sirna/product/BONAC Corporation Average 90 stars, based on 1 article reviews
rnai negative control sirna - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
ST Pharm Co
predesigned negative control sirna against gfp Predesigned Negative Control Sirna Against Gfp, supplied by ST Pharm Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/predesigned negative control sirna against gfp/product/ST Pharm Co Average 90 stars, based on 1 article reviews
predesigned negative control sirna against gfp - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Gene Universal Inc
negative control sirna Negative Control Sirna, supplied by Gene Universal Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/negative control sirna/product/Gene Universal Inc Average 90 stars, based on 1 article reviews
negative control sirna - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Merck KGaA
non-targeting sirna mission sirna universal control#1 Non Targeting Sirna Mission Sirna Universal Control#1, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/non-targeting sirna mission sirna universal control#1/product/Merck KGaA Average 90 stars, based on 1 article reviews
non-targeting sirna mission sirna universal control#1 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
B-Bridge Inc
negative control sirna ![]() Negative Control Sirna, supplied by B-Bridge Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/negative control sirna/product/B-Bridge Inc Average 90 stars, based on 1 article reviews
negative control sirna - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Qiagen
double-stranded sirnas to the selected regions of ac2-7 ![]() Double Stranded Sirnas To The Selected Regions Of Ac2 7, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/double-stranded sirnas to the selected regions of ac2-7/product/Qiagen Average 90 stars, based on 1 article reviews
double-stranded sirnas to the selected regions of ac2-7 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Kaneka Corp
non-specific sirna control ![]() Non Specific Sirna Control, supplied by Kaneka Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/non-specific sirna control/product/Kaneka Corp Average 90 stars, based on 1 article reviews
non-specific sirna control - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Qiagen
cntfr-sirna ![]() Cntfr Sirna, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cntfr-sirna/product/Qiagen Average 90 stars, based on 1 article reviews
cntfr-sirna - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Annals of Surgical Oncology
Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer
doi: 10.1245/s10434-010-1523-0
Figure Lengend Snippet: Inhibition of p600 reduces the invasiveness of gastric cancer cells. a Effect of p600-targeting siRNA in the MKN45 gastric cancer cell line. ( i ) Reverse transcriptase–polymerase chain reaction (RT-PCR). ( ii ) Western blot test. b Effect of p600-targeting siRNA in the AGS gastric cancer cell line. ( i ) RT-PCR. ( ii ) Western blot test. β-Actin was used as the internal control for immunoblotting. p600 expression in both gastric cancer cell lines was inhibited by p600-targeting siRNA for at least 5 days. c ( i ) Microscopic appearance of the invading control siRNA-transfected MKN45 cells, and ( ii ) p600-targeting siRNA-transfected MKN45 cells . ( iii ) Number of invaded cells. d ( i ) Microscopic appearance of invading control siRNA-transfected AGS cells, and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Number of invaded cells. Data are expressed as mean ± SD. Inhibition of p600 reduced the invasiveness of both gastric cancer cell lines (MKN45, P = 0.004; AGS, P < 0.001). e Western blot analysis of urokinase-type plasminogen activator (uPA), matrix metalloproteinase (MMP)-2, MMP-7, and MMP-9 expression levels. ( i ) MKN45. ( ii ) AGS. β-Actin was used as the internal control for immunoblotting. MMP-7 expression was decreased by inhibition of p600 in both gastric cancer cell lines. f Western blot analysis of E-cadherin expression in MKN45 gastric cancer cells. β-Actin was used as the internal control for immunoblotting. Expression of E-cadherin was higher in p600-targeting siRNA-transfected MKN45 cells than in control siRNA-transfected MKN45 cells
Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or
Techniques: Inhibition, Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Western Blot, Expressing, Transfection
Journal: Annals of Surgical Oncology
Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer
doi: 10.1245/s10434-010-1523-0
Figure Lengend Snippet: Inhibition of p600 does not affect cell proliferation, apoptosis, and colony-formation capacity under anchorage-dependent conditions. a Proliferation assay under anchorage-dependent conditions. There was no significant difference between p600 -targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of cell proliferation under anchorage-dependent conditions. b Proportion of apoptotic cells in ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells as analyzed by flow cytometry. There was no significant difference between p600-targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of apoptotic cells proportion. c Macroscopic appearance of colonies formed under anchorage-dependent conditions; ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600 - targeting siRNA-transfected MKN45 cells. ( iii ) Data graph. Data are expressed as mean ± SD. There was no significant difference between p600 -targeting siRNA-transfected MKN45 cells and control siRNA-transfected MKN45 cells in terms of colony-formation capacity under anchorage-dependent conditions
Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or
Techniques: Inhibition, Proliferation Assay, Transfection, Flow Cytometry
Journal: Annals of Surgical Oncology
Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer
doi: 10.1245/s10434-010-1523-0
Figure Lengend Snippet: Inhibition of p600 sensitizes gastric cancer cells to anoikis and reduces their viability under anchorage-independent conditions. a Cell viability assay under anchorage-independent conditions. The viability of ( i ) MKN45 and ( ii ) AGS gastric cancer cells were reduced by inhibition of p600 (MKN45, P = 0.033; AGS, P < 0.001). b Proportion of apoptotic (anoikis) cells under anchorage-independent conditions in ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells as analyzed by flow cytometry. c Proportion of apoptotic (anoikis) cells in ( i ) control siRNA-transfected AGS cells and ( ii ) p600-targeting siRNA-transfected AGS cells as analyzed by flow cytometry. d Macroscopic appearance of colonies formed in soft agar; ( i ) control siRNA-transfected MKN45 cells and ( ii ) p600-targeting siRNA-transfected MKN45 cells. ( iii ) Number of colonies. e Macroscopic appearance of colonies formed in soft agar; ( i ) control siRNA-transfected AGS cells and ( ii ) p600-targeting siRNA-transfected AGS cells. ( iii ) Data graph. Data are expressed as mean ± SD. The number of colonies was reduced by inhibition of p600 (MKN45, P < 0.001; AGS, P = 0.003)
Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or
Techniques: Inhibition, Viability Assay, Transfection, Flow Cytometry
Journal: Annals of Surgical Oncology
Article Title: Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer
doi: 10.1245/s10434-010-1523-0
Figure Lengend Snippet: Inhibition of p600 suppresses the establishment of intraperitoneal disseminated tumors. a Macroscopic appearance of the intraperitoneal disseminated nodules; ( i ) control siRNA-transfected MKN45 cells injected into SCID mice, and ( ii ) p600-targeting siRNA-transfected MKN45 cells ( n = 10/group). Arrows indicate intraperitoneal disseminated nodules. ( iii ) Resected disseminated nodules from SCID mice. b Data graph. Data are expressed as mean ± SD. The number of intraperitoneal disseminated nodules was significantly reduced by p600 inhibition ( P < 0.001)
Article Snippet: Cells were transfected with p600-targeting small interfering RNA (siRNA) (sense, ggaaagaacaucauuguuaTT; antisense, uaacaaugauguucuuuccTT) (B-Bridge, Mountain View, CA), or
Techniques: Inhibition, Transfection, Injection
Journal: PLoS ONE
Article Title: A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2 / TFF1 Gene
doi: 10.1371/journal.pone.0009665
Figure Lengend Snippet: Real time RT-PCR analysis of pS2 transcripts in HeLa and MBD2 -depleted HeLa cells (HeLa cells pretreated for 72 h with MBD2 siRNA) transfected with an MBD2 vector expressing a transcript resistant to RNAi (pRev-MBD2 vector) or with an empty basic vector pGL3. Transcriptional expression of pS2 was analyzed 24 h after transfection. The fold change of pS2 expression was calculated from the relative pS2 mRNA in pRev-MBD2-transfected cells compared to pGL3-transfected cells. Values are presented as the mean ± standard deviation of at least three independent transfection experiments. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).
Article Snippet: siRNA duplexes for MBD2 (sense: 5′-GGAGGAAGUGUACCGAAATT-3′ ; antisense: 5′-UUUUCGGAUCACUUCCUCCTT-3′ ) and
Techniques: Quantitative RT-PCR, Transfection, Plasmid Preparation, Expressing, Standard Deviation
Journal: PLoS ONE
Article Title: A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2 / TFF1 Gene
doi: 10.1371/journal.pone.0009665
Figure Lengend Snippet: ( A ) Transcriptional expression of pS2 was analyzed using relative RT-PCR in HeLa cells expressing ERα and/or depleted in MBD2. Mock, mock-treated HeLa cells. ER, HeLa cells 24 h after transfection with a human ERα expression vector, HEG0. MBD2 siRNA, HeLa cells pretreated for 72 h with MBD2 siRNA and again for 24 h. MBD2 siRNA + ER, HeLa cells pretreated for 72 h with MBD2 siRNA, then cotransfected with MBD2 siRNA and HEG0 for 24 h. OHT, 24 h treatment with 4-hydroxytamoxifen. MCF7, MCF7 cells. ( B ) Bar chart showing the fold change of pS2 expression in HeLa cells expressing ERα and/or depleted in MBD2. pS2 transcripts were quantified by real time RT-PCR. The fold change was calculated from the relative pS2 mRNA in treated compared to mock-treated cells. Each bar represents the mean ± standard deviation of three analyses. A significant difference between the two cell groups is represented by an asterisk * (P<0.05).
Article Snippet: siRNA duplexes for MBD2 (sense: 5′-GGAGGAAGUGUACCGAAATT-3′ ; antisense: 5′-UUUUCGGAUCACUUCCUCCTT-3′ ) and
Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Transfection, Plasmid Preparation, Quantitative RT-PCR, Standard Deviation